Literature DB >> 35950408

[Application of Raman-based technologies in the detection of urological tumors].

Z Hao1, S H Yue1, L Q Zhou1.   

Abstract

Urinary system tumors affect a huge number of individuals, and are frequently recurrent and progressing following surgery, necessitating lifelong surveillance. As a result, early and precise diagnosis of urinary system cancers is important for prevention and therapy. Histopathology is now the golden stan-dard for the diagnosis, but it is invasive, time-consuming, and inconvenient for initial diagnosis and re-gular follow-up assessment. Endoscopy can directly witness the tumor's structure, but intrusive detection is likely to cause harm to the patient's organs, and it is apt to create other hazards in frequently examined patients. Imaging is a valuable non-invasive and quick assessment tool; however, it can be difficult to define the type of lesions and has limited sensitivity for early tumor detection. The conventional approaches for detecting tumors have their own set of limitations. Thus, detection methods that combine non-invasive detection, label-free detection, high sensitivity and high specificity are urgently needed to aid clinical diagnosis. Optical diagnostics and imaging are increasingly being employed in healthcare settings in a variety of sectors. Raman scattering can assess changes in molecular signatures in cancer cells or tissues based on the interaction with vibrational modes of common molecular bonds. Due to the advantages of label-free, strong chemical selectivity, and high sensitivity, Raman scattering, especially coherent Raman scattering microscopy imaging with high spatial resolution, has been widely used in biomedical research. And quantity studies have shown that it has a good application in the detection and diagnosis of bladder can-cer, renal clear cell carcinoma, prostate cancer, and other cancers. In this paper, several nonlinear imaging techniques based on Raman scattering technology are briefly described, including Raman spectroscopy, coherent anti-Stokes Raman scattering, stimulated Raman scattering, and surface-enhanced Raman spectroscopy. And we will discuss the application of these techniques for detecting urologic malignancy. Future research directions are predicted using the advantages and limitations of the aforesaid methodologies in the research. For clinical practice, Raman scattering technology is intended to enable more accurate, rapid, and non-invasive in early diagnosis, intraoperative margins, and pathological grading basis for clinical practice.

Entities:  

Keywords:  Diagnosis; Spectrum analysis, Raman; Urologic neoplasms

Mesh:

Substances:

Year:  2022        PMID: 35950408      PMCID: PMC9385527     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  50 in total

1.  Label-free detection of multiple genitourinary cancers from urine by surface-enhanced Raman spectroscopy.

Authors:  Xiaoyu Cui; Tao Liu; Xiaosong Xu; Zeyin Zhao; Ye Tian; Yue Zhao; Shuo Chen; Zhe Wang; Yiding Wang; Dayu Hu; Shui Fu; Guangyi Shan; Jiarun Sun; Kaixin Song; Yu Zeng
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2020-05-28       Impact factor: 4.098

2.  Raman molecular imaging: a novel spectroscopic technique for diagnosis of bladder cancer in urine specimens.

Authors:  Amos Shapiro; Ofer N Gofrit; Galina Pizov; Jeffrey Kirk Cohen; John Maier
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

3.  Raman spectroscopy: a novel experimental approach to evaluating renal tumours.

Authors:  Karim Bensalah; Julien Fleureau; Denis Rolland; Olivier Lavastre; Nathalie Rioux-Leclercq; François Guillé; Jean-Jacques Patard; Lotfi Senhadji; Renaud de Crevoisier
Journal:  Eur Urol       Date:  2010-06-11       Impact factor: 20.096

4.  Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness.

Authors:  Shuhua Yue; Junjie Li; Seung-Young Lee; Hyeon Jeong Lee; Tian Shao; Bing Song; Liang Cheng; Timothy A Masterson; Xiaoqi Liu; Timothy L Ratliff; Ji-Xin Cheng
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

5.  Discrimination between nontumor bladder tissue and tumor by Raman spectroscopy.

Authors:  Bas W D de Jong; Tom C Bakker Schut; Kees Maquelin; Theo van der Kwast; Chris H Bangma; Dirk-Jan Kok; Gerwin J Puppels
Journal:  Anal Chem       Date:  2006-11-15       Impact factor: 6.986

6.  Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy.

Authors:  Christian W Freudiger; Wei Min; Brian G Saar; Sijia Lu; Gary R Holtom; Chengwei He; Jason C Tsai; Jing X Kang; X Sunney Xie
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

7.  Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.

Authors:  Na Chen; Ming Rong; Xiaoguang Shao; Heng Zhang; Shupeng Liu; Baijun Dong; Wei Xue; Tingyun Wang; Taihao Li; Jiahua Pan
Journal:  Int J Nanomedicine       Date:  2017-07-27

Review 8.  Surface-enhanced Raman spectroscopy: benefits, trade-offs and future developments.

Authors:  Ana Isabel Pérez-Jiménez; Danya Lyu; Zhixuan Lu; Guokun Liu; Bin Ren
Journal:  Chem Sci       Date:  2020-04-14       Impact factor: 9.825

9.  The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro.

Authors:  P Crow; N Stone; C A Kendall; J S Uff; J A M Farmer; H Barr; M P J Wright
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

10.  ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.

Authors:  Houguang He; Conghui Han; Lin Hao; Guanghui Zang
Journal:  Oncol Lett       Date:  2016-05-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.